Nebula Data Intel– Disrupting Big Data in The Medical Field is Featured on FOX TV

Dr. David Watts Chairman of the Board of Directors and CEO of Nebula Data Intel, and is also the president of the board of directors for American Association for Accreditation of Ambulatory Surgery Facilities, Inc (AAAASF). Dr. Watts provides the overall strategic vision for Nebula Data Intel. A personable, technically proficient physician, he always considers the health, safety, and desires of his patients first. He has completed more than 29,000 surgical procedures that combine art, science, and the latest technology to improve the appearance and self-esteem of patients.

Dr. Watts was recently a featured guest on The Morning Blend FOX TV show with Amy Lyn  Tampa, FL. Watts discussed how NDI is disrupting Big Data in the medical industry. They also talked about how NDI’s collected data can be used both by facilities to make decisions that directly affect their bottom line and also sold to and used in different markets.

The Problem

Outpatient surgery centers are responsible for 60-65% of the total surgeries performed in the US, with that number expected to rise in the next 3 years. The challenges that these facilities face have both a financial and clinical impact on the overall quality of care that patients receive.  

According to Managed Healthcare Executive’s 2017 State of the Industry Survey, challenges in medicine abound:

  • Complying with new government requirements & mandates
  • Implementing value-based reimbursement
  • Employing Big Data to address pain points
  • Addressing rising pharmaceutical costs
  • Pricing
  • Complication rates
  • Technology acquisitions and investments

For medical supply and pharmaceutical corporations, there is limited knowledge of how or the quantity of a product is being used at the procedure level. Feedback on product issues is often delayed and is provided at the individual item level – meaning physicians are not actively reporting the type of procedure that the issue occurred in and what other devices and/or medications were prescribed where the issue was noted.

There is also no long-term patient satisfaction data that exists in the marketplace. For example, after a knee implant, the facility will collect a patient satisfaction survey at the time of surgery, but not at the 3-month, 6-month and 1-year mark post physical therapy to get the patient’s perspective on the success of the procedure. Most of the performance data is short term. Long-term implications and data trending of this kind could be incredibly valuable to healthcare driven corporations.

Nebula Data Intel, LLC (NDI), in collaboration with the American Association for Accreditation of Surgery Facilities (AAAASF), is disrupting this stagnant marketing with a revolutionary technology that captures, refines, and redistributes medical data.

NDI is looking to raise relevant funding to support our growth and reach a Phase I target of 1,000 participating facilities. Our analysis performed in conjunction with Harvard University ensures statistically relevant results.

Nebula Data Intel is undergoing their series “A” raise with their most enticing offer for early investor which includes a revenue-sharing component. To learn more about the project, please visit .

“With an investment in Nebula Data Intel, you’re really getting in on the sub-basement of big data in the medical field that will drive these quantum computers and end up being a commodity.” – David C. Watts, MD.